Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cognitive Therapy vs Paroxetine in Social Phobia
NCT00184106Phase 4Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Oct 2004
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of paroxetine in Social Anxiety Disorder (SAD) (4 arms), sponsored by Norwegian University of Science and Technology. Primary endpoint: Proportion of Responders at 24 weeks. Started Oct 2004; status: completed.
02
Drugs
paroxetine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00184106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00184106.